ABSTRACT
OBJECTIVE: This study aimed to identify psychoeducational interventions applied to parents of children with chronic diseases and evaluate their impact on their quality of life (QoL). METHODS: It was conducted in six databases, complemented by references from the included studies and other reviews, manual search, and contact with experts. We included primary studies on parents of children with chronic diseases that studied psychoeducational interventions versus standard care. RESULTS: We screened 6604 titles and abstracts, reviewed the full text of 60 records, and included 37 primary studies. Half of the studies were on Asthma. We found three intervention formats: one-to-one (43%), groups (49%), and combined approach with individual and group settings (8%). More than 60% of the included studies found statistically significant differences between the intervention and the control group (p < 0.05). CONCLUSION: Several interventions have shown efficacy in improving parental QoL. Despite that, there is insufficient evidence of interventions' implementation. PRACTICE IMPLICATIONS: A holistic approach encompassing the patient and the family's biopsychosocial dimensions is fundamental in successfully managing chronic disease in children. It is vital to design and implement interventions accommodating the common issues experienced by children, parents, and families that deal with chronic childhood conditions. Systematic review registration number PROSPERO 2018 CRD42018092135.
Subject(s)
Asthma , Quality of Life , Child , Chronic Disease , Humans , ParentsABSTRACT
Trazodone is used as an antidepressant in doses between 150 and 600 mg. At lower doses, it is commonly used to treat insomnia. There are few case reports about confusional symptoms as an undesirable side effect of this drug. We report a case of a patient who presented with delirium after prescription of trazodone 100 mg. She required hospitalisation but, shortly after discontinuation of trazodone, the symptoms disappeared without antipsychotic medication. Seven months after the episode, the patient remains asymptomatic.
Subject(s)
Antidepressive Agents, Second-Generation/adverse effects , Delirium/chemically induced , Trazodone/adverse effects , Adult , Antidepressive Agents, Second-Generation/administration & dosage , Female , Hospitalization , Humans , Trazodone/administration & dosageABSTRACT
ABSTRACT Trazodone is used as an antidepressant in doses between 150 and 600 mg. At lower doses, it is commonly used to treat insomnia. There are few case reports about confusional symptoms as an undesirable side effect of this drug. We report a case of a patient who presented with delirium after prescription of trazodone 100 mg. She required hospitalisation but, shortly after discontinuation of trazodone, the symptoms disappeared without antipsychotic medication. Seven months after the episode, the patient remains asymptomatic.
RESUMEN La trazodona se usa como antidepresivo en dosis de 150-600 mg. En dosis más bajas, se usa comúnmente para tratar el insomnio. Hay pocos reportes de caso sobre síntomas confusionales como un efecto secundario indeseable de este medicamento. Se presenta el caso de una paciente que acudió con delirio después de la prescripción de trazodona 100 mg. La paciente requirió hospitalización pero, poco después de la interrupción de la trazodona, los síntomas desaparecieron sin medicación antipsicótica. A los 7 meses del episodio, la paciente permanecía asintomática.
Subject(s)
Humans , Female , Adult , Trazodone , Delirium , Rebound Effect , Dosage , Prescriptions , Sleep Initiation and Maintenance Disorders , Antidepressive AgentsABSTRACT
Objetivo: analisar se as estratégias de comunicação de más notícias pelos profissionais de saúde ao pacienteadulto e sua família são adequadas. Método: pesquisa realizada em bases de dados internacionais(EBSCOhost, CINAHL, SciELO), obtendo-se dez artigos publicados entre 2005 e 2011. Pretendemos responder àquestão de pesquisa > Resultados: foram analisados dez artigos e constatou-seque não existe uma norma para comunicar más notícias, pois cada pessoa tem as suas caraterísticas e aatuação dos profissionais de saúde deve ser adequada a cada situação. Conclusão: a comunicação de másnotícias é uma das tarefas mais difíceis na prática clínica dos profissionais de saúde, incluindo os enfermeiros.Devido à relação interpessoal desenvolvida entre o enfermeiro e o paciente, este desempenha um papel muitoimportante no momento de comunicar uma má notícia.
